Revvity Company Insiders
| RVTY Stock | 87.46 0.09 0.10% |
About 52% of Revvity's investors are presently acquiring. The analysis of insiders' sentiment of trading Revvity stock suggests that some insiders are bullish at this time. Revvity employs about 11 K people. The company is managed by 16 executives with a total tenure of roughly 25667 years, averaging almost 1604.0 years of service per executive, having 687.5 employees per reported executive.
Insider Sentiment
Impartial
Selling | Buying |
Latest Trades
| 2026-02-05 | Ro Khanna | Disposed @ 99.32 | |||
| 2026-01-29 | Ro Khanna | Acquired @ 108.52 | |||
| 2025-09-29 | Ro Khanna | Acquired @ 84.23 | |||
| 2025-09-12 | Gilbert Ray Cisneros, Jr. | Acquired @ 82.83 | |||
| 2025-08-26 | Ro Khanna | Disposed @ 91.35 | |||
| 2025-08-13 | Gilbert Ray Cisneros, Jr. | Acquired @ 90.91 | |||
| 2025-08-04 | Ro Khanna | Disposed @ 88.34 | |||
| 2025-07-23 | Gilbert Ray Cisneros, Jr. | Acquired @ 99.57 | |||
| 2025-07-22 | Lisa C. McClain | Disposed @ 96.26 | |||
| 2025-06-17 | Lisa C. McClain | Acquired @ 94.22 | |||
| 2025-06-11 | Gilbert Ray Cisneros, Jr. | Acquired @ 96.11 | |||
| 2025-05-28 | Gilbert Ray Cisneros, Jr. | Acquired @ 91.35 | |||
| 2025-05-19 | Ro Khanna | Acquired @ 94.31 | |||
| 2025-04-15 | Ro Khanna | Disposed @ 95.54 | |||
| 2025-04-08 | Robert Bresnahan, Jr. | Disposed @ 91.58 | |||
| 2025-02-28 | April McClain Delaney | Disposed @ 112.28 | |||
| 2025-02-25 | Robert Bresnahan, Jr. | Acquired @ 115.71 | |||
| 2025-01-30 | Joel S Goldberg | Disposed 15170 @ 126.73 | View | ||
| 2025-01-07 | Tajinder S Vohra | Disposed 5492 @ 116.81 | View |
Following insider trading sentiment in Revvity can help investors add context around confidence, timing, and operating risk while the public narrative is still evolving. This data should be handled carefully because insiders are required to disclose trades publicly and the motives behind a trade are not always purely directional.
Acquired vs Disposed
Filed vs Not Filed
Insider sentiment for Revvity reflects how officers, directors, and other significant holders appear to view the company's prospects based on their own disclosed trading behavior. The better interpretation comes from the pattern rather than from one isolated trade, especially when transactions may also reflect compensation or liquidity needs.
latest congressional trading
Congressional trading tied to Revvity draws attention because lawmakers and their families are required to disclose transactions that could create perceived conflicts of interest. Used properly, this data is another governance and disclosure signal rather than a standalone trading system.
| 2025-10-13 | Representative Gilbert Cisneros | Acquired under $15,000 | Verify | ||
| 2025-10-03 | Representative Ro Khanna | Acquired under $15,000 | Verify | ||
| 2025-09-12 | Representative Gilbert Cisneros | Acquired under $15,000 | Verify |
Management Team Effectiveness
The company has return on total asset (ROA) of 2.22 % indicating that every $100 of assets deployed produced a $2.22 return. This is below the industry norm. Similarly, it shows a return on stockholder's equity (ROE) of 3.22 %, implying that it produced a $3.22 return per $100 of shareholder investment.Per market data dated March 18, 2026, Common Stock Shares Outstanding is projected to grow to approximately 124.9 M. Also, Net Income Applicable To Common Shares is projected to grow to approximately 678.6 M.
Insider Trading Activities
Insider activity around Revvity matters because officers and directors often act on business changes before the market catches up. It trades on NYSE in US. The business currently sits in the Healthcare sector and the Diagnostics & Research industry.
Outstanding Bonds
Outstanding bonds linked to Revvity can tell investors a great deal about how the company finances itself beyond common equity markets. Used together with earnings and cash-flow analysis, the bond stack can reveal whether leverage is a manageable tool or a developing constraint.
| US714046AG46 Corp BondUS714046AG46 | View | |
| PKI 255 15 MAR 31 Corp BondUS714046AH29 | View | |
| PKI 225 15 SEP 31 Corp BondUS714046AN96 | View | |
| PKI 3625 15 MAR 51 Corp BondUS714046AJ84 | View | |
| PKI 19 15 SEP 28 Corp BondUS714046AM14 | View |
Corporate Filings
| 16th of March 2026 Other Reports | ViewVerify | |
F4 | 10th of March 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 6th of March 2026 Other Reports | ViewVerify | |
F4 | 26th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
F4 | 25th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10K | 24th of February 2026 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
F4 | 19th of February 2026 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 17th of February 2026 An amended filing to the original Schedule 13G | ViewVerify |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 117.7 M | Current Value 113.2 M | Average Shares Outstanding 113.6 M | Quarterly Volatility 10 M |
Macro event markers
Holders Distribution
A large institutional presence around Revvity deserves attention because well-resourced investors can establish or unwind positions quickly enough to change the market character of the security. The better interpretation comes from watching concentration, turnover, and changes in holder behavior instead of assuming institutional ownership is automatically bullish.
Market Cap and Value
Workforce Comparison
Revvity is rated below average in number of employees among leading competitors. The total workforce of Health Care industry is at this time estimated at about 201,517. Revvity holds roughly 11,000 in number of employees claiming about 5% of equities under Health Care sector.
Profit Margins
The company has Profit Margin (PM) of 8.0 %, which may suggest that the company executes well on its competitive strategy. This is above industry benchmarks. Similarly, it shows Operating Margin (OM) of 20.0 %, which implies that for every $100 of revenue, the company generates $20.0 of operating income.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.3 | 0.4807 |
|
| |||||
| Operating Profit Margin | 0.088 | 0.1452 |
|
| |||||
| Pretax Profit Margin | 0.0633 | 0.0665 |
|
|
Insider Trading History
The insider timeline for Revvity shows how management behavior has tracked against the stock's price over time. Sustained buying at different price levels is a stronger signal than routine scheduled sales under 10b5-1 plans.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2026-03-01 | 0.5714 | 16 | 28 | 247,784 | 103,422 |
| 2025-12-01 | 0.5 | 1 | 2 | 9,420 | 9,445 |
| 2025-09-01 | 0.75 | 3 | 4 | 89,011 | 13,391 |
| 2025-06-01 | 9.0 | 18 | 2 | 22,136 | 633.00 |
| 2025-03-01 | 0.8333 | 15 | 18 | 175,823 | 44,210 |
| 2024-12-01 | 0.1 | 1 | 10 | 18,365 | 43,216 |
| 2024-06-01 | 4.5 | 18 | 4 | 20,146 | 4,140 |
| 2024-03-01 | 0.8148 | 22 | 27 | 339,187 | 138,967 |
Notable Stakeholders
A Revvity stakeholder is any individual or group with an interest in the outcome of the business, which is why stakeholder analysis can reveal who may influence strategy and oversight. Used properly, stakeholder review helps investors stay aware of the people and incentives that may be shaping key decisions behind the scenes.
| Prahlad Singh | President CEO | Profile | |
| Maxwell Krakowiak | Senior CFO | Profile | |
| Andrew Okun | Chief VP | Profile | |
| Masoud Toloue | VP Diagnostics | Profile | |
| Anita Gonzales | VP Officer | Profile | |
| Joel Goldberg | General Administration | Profile | |
| Jayashree Thacker | Senior Officer | Profile | |
| Madhuri FACMG | Senior Officer | Profile | |
| Bryan Kipp | Senior Licensing | Profile | |
| Miriame Victor | Senior Officer | Profile | |
| Magali Four | Senior Officer | Profile | |
| Stephen Willoughby | Senior ESG | Profile | |
| Tajinder Vohra | Senior Operations | Profile | |
| Robert Friel | Advisor | Profile | |
| Daniel Tereau | Senior Development | Profile | |
| Arvind SundarRajan | Vice Technology | Profile |
Management Information & Data Sources
Revvity is a mid-cap company in Life Sciences Tools & Services, Pharmaceuticals, Biotechnology & Life Sciences, Health Care. Executive review focuses on insiders, senior management, and employee signals. Management quality is often reflected indirectly through margin durability, reinvestment choices, and governance signals. CEO is Prahlad Singh with 11,000 employees and 16 reported executives.
Unless otherwise specified, data for Revvity is compiled from periodic company reporting and market reference feeds and standardized for comparability. Updates may occur throughout the day. Insider and management fields are mapped from published filings and company disclosures.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial BoardWorkforce Efficiency and Productivity
Investors reviewing Revvity can use workforce efficiency as another lens on execution, especially when comparing similar businesses in the same industry. This is most informative when investors want to connect operating scale with efficiency rather than reviewing headcount in isolation.
Revvity Manpower Efficiency
Return on Revvity Manpower
| Revenue Per Employee | 259.6K | |
| Revenue Per Executive | 178.5M | |
| Net Income Per Employee | 21.9K | |
| Net Income Per Executive | 15.1M | |
| Working Capital Per Employee | 82.6K | |
| Working Capital Per Executive | 56.8M |
Popular Tools for Revvity Stock analysis
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |